Retrospective analysis of response to rituximab in chronic inflammatory demyelinating polyneuropathy refractory to first-line therapy.

Fatehi, Farzad; Okhovat, Ali Asghar; Panahi, Akram; Ziaaddini, Bentolhoda; Rajabally, Yusuf A; Nafissi, Shahriar

Fatehi, Farzad; Okhovat, Ali Asghar; Panahi, Akram; Ziaaddini, Bentolhoda; Rajabally, Yusuf A; Nafissi, Shahriar.

Affiliation

Fatehi F; Neurology Department, Neuromuscular Research Center, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran.
Okhovat AA; Neurology Department, Neuromuscular Research Center, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran.
Panahi A; Neurology Department, Neuromuscular Research Center, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran.
Ziaaddini B; Neurology Department, Neuromuscular Research Center, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran.
Rajabally YA; Neurology Department, Neuromuscular Research Center, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran.
Nafissi S; Aston Medical School, Aston University, Birmingham, UK.

J Peripher Nerv Syst ; 26(4): 469-474, 2021 12.

Article in En | MEDLINE | ID: mdl-34469032

Subject(s)
Key words

anti-nodal/paranodal antibodies; chronic inflammatory demyelinating polyneuropathy; refractory; rituximab

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Polyradiculoneuropathy, Chronic Inflammatory Demyelinating Type of study: Observational_studies / Prognostic_studies Limits: Adolescent / Adult / Child / Humans / Middle aged Country/Region as subject: Asia Language: En Journal: J Peripher Nerv Syst Journal subject: NEUROLOGIA Year: 2021 Document type: Article Affiliation country: Irán Country of publication: Estados Unidos

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google